A belated post on the announcement on 9th July that UK will be testing a subscription model for antibiotics that hopes to encourage the pharmaceutical industry to develop new antibiotics in the future. The background to this is that – unlike most other drugs and medical devices – there is acknowledged market failure where antibiotics […]